Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials

BACKGROUND: The clinical efficacy and safety of a mometasone furoate/formoterol fumarate (MF/F) fixed-dose combination formulation administered via a metered-dose inhaler was investigated in patients with moderate to very severe chronic obstructive pulmonary disease (COPD). METHODS: Two 52-week, mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashkin, Donald P, Doherty, Dennis E, Kerwin, Edward, Matiz-Bueno, Carlos E, Knorr, Barbara, Shekar, Tulin, Gates, Davis, Staudinger, Heribert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276258/
https://www.ncbi.nlm.nih.gov/pubmed/22334770
http://dx.doi.org/10.2147/COPD.S29444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276258/
https://www.ncbi.nlm.nih.gov/pubmed/22334770
http://dx.doi.org/10.2147/COPD.S29444

Ejemplares similares